Chronic Hepatitis (Chc), Viral Polymerase Nucleotide Inhibitor & Process Patents Review and Evaluation, Preparation of Sofosbuvir

Krishna Sarma Pathy
Additional contact information
Krishna Sarma Pathy: Head R&D-QC/QA: IPL Research Centre, India

Biomedical Journal of Scientific & Technical Research, 2019, vol. 21, issue 5, 16214-16219

Abstract: Sofosbuvir is a viral polymerase nucleotide inhibitor that was approved in December 2013 by the United States Food and Drug Administration (FDA), and in January 2014 by the European Medicines Agency for the treatment of HCV infection [1]...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research; Chronic Hepatitis (Chc); Viral Polymerase Nucleotide Inhibitor & Process Patents Review and Evaluation; Preparation of Sofosbuvir (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.003667.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.003667.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:21:y:2019:i:5:p:16214-16219

DOI: 10.26717/BJSTR.2019.21.003667

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().